-+ 0.00%
-+ 0.00%
-+ 0.00%

ISPIRE TECHNOLOGY: ACCEPTANCE REVIEW LETTER FROM FDA CONFIRMING THAT IKE TECH'S PMTA MEETS REGULATORY REQUIREMENTS

Reuters·06/06/2025 12:37:18

Please log in to view news